Modulation of intestinal gas dynamics in healthy human volunteers by the 5-HT4 receptor agonist tegaserod

American Journal of Gastroenterology

Volumn 101, Issue 8, 2006, Pages 1858-1865

  Coleski, Radoslav ^a   Owyang, Chung ^a   Hasler, William L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Box 0362 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN 4 AGONIST; TEGASEROD;

ADULT; ARTICLE; BAROSTAT; BLOATING; CATHETER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GAS FLOW; GAS TRANSPORT; HUMAN; HUMAN EXPERIMENT; IRRITABLE COLON; JEJUNUM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SEROTONINERGIC SYSTEM;

ADMINISTRATION, ORAL; ADULT; FEMALE; FLATULENCE; GASES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRANSIT; HUMANS; INDOLES; MALE; MIDDLE AGED;

EID: 33746682516     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00708.x     Document Type: Article

References (31)

1. Sandler RS, Stewart WF, Liberman JN, et al. Abdominal pain, bloating, and diarrhea in the United States: Prevalence and impact. Dig Dis Sci 2000;45:1166-71.
2. Hahn B, Watson M, Yan S, et al. Irritable bowel syndrome symptom patterns: Frequency, duration, and severity. Dig Dis Sci 1998;43:2715-8.
3. Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999;94:1320-6.
4. Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001;48:14-9.
5. Serra J, Salvioli B, Azpiroz F, et al. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology 2002;123:700-6.
6. 4 receptor mediated facilitation of the emptying phase of the peristaltic reflex in the guinea-pig isolated ileum. Br J Pharmacol 1993;110:1572-8.
7. 1P receptors on sensory CGRP neurons. Am J Physiol 1996;270:G778-82.
8. 4 receptor stimulation of colonic peristaltic reflex and basal tonic colon activity by tegaserod in healthy humans: Possible mechanisms of its action in constipation (abstract). Gastroenterology 2004;126:109.
9. 4 receptors in two models of gastrointestinal transit in mice. Neurosci Lett 2002;326:163-6.
10. 4 receptor antagonism in irritable bowel syndrome: Effect of SB-207266-A on rectal sensitivity and small bowel transit. Aliment Pharmacol Ther 1999;13:1437-44.
11. Prather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000;118:463-8.
12. 4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001;15:1655-66.
13. Gonlachanvit S, Coleski R, Owyang C, et al. Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers. Gut 2004;53:1577-82.
14. Appel-Dingemanse S, Hirschberg Y, Osborne S, et al. Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tega-serod (HTF 919). Eur J Clin Pharmacol 2001;56:889-91.
15. Serra J, Azpiroz F, Malagelada JR. Intestinal gas dynamics and tolerance in humans. Gastroenterology 1998;115:542-50.
16. Levitt MD. Follow-up of a flatulent patient. Dig Dis Sci 1979;24:652-4.
17. Ramirez FC, Lee K, Graham DY. All lactase preparations are not the same: Results of a prospective, randomized, placebo-controlled trial. Am J Gastroenterol 1994;89:566-70.
18. Jain NK, Patel VP, Pitchumoni CS. Efficacy of activated charcoal in reducing intestinal gas: A double-blind clinical trial. Am J Gastroenterol 1986;81:532-5.
19. Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med 1975;293:524-6.
20. Galati JS, McKee DP, Quigley EM. Response to intraluminal gas in irritable bowel syndrome. Motility versus perception. Dig Dis Sci 1995;40:1381-7.
21. 4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998;115:370-80.
22. 4 receptor-mediated facilitation of the emptying phase of the peristaltic reflex in the marmoset isolated ileum. Br J Pharmacol 1996;117:1679-84.
23. Sims MA, Hasler WL, Chey WD, et al. Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans. Gastroenterology 1995;108:350-9.
24. 3 mediation of human gastrocolonic response and colonic peristaltic reflex. Am J Physiol 1998;275:G498-505.
25. 3 pathways. Am J Physiol Gastrointest Liver Physiol 2002;283:G400-7.
26. 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001;15:1745-51.
27. Caldarella MP, Serra J, Azpiroz F, et al. Prokinetic effects in patients with intestinal gas retention. Gastroenterology 2002;122:1748-55.
28. Gonlachanvit S, Coleski R, Hasler W. Luminal contents modulate intestinal gas transit in healthy humans: Effects of fiber vs. colonic lavage (abstract). Gastroenterology 2003;124:T1802.
29. Gonlachanvit S, Coleski R, Hasler W. Correlation of gas transit with small bowel motility during fasting and postprandial periods in healthy humans (abstract). Gastroenterology 2004;126:107.
30. Tougas G, Snape WJ, Otten MH, et al. Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2002;16:1701-8.
31. Gonlachanvit S, Coleski R, Hasler W. Nutrient modulation of intestinal gas dynamics in healthy humans depends on caloric content and physical properties (abstract). Gastroenterology 2003;124:307.